Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

被引：0
作者：
François-Clément Bidard
David Hajage
Thomas Bachelot
Suzette Delaloge
Etienne Brain
Mario Campone
Paul Cottu
Philippe Beuzeboc
Emilie Rolland
Claire Mathiot
Jean-Yves Pierga
机构：
[1] Institut Curie,Department of Medical Oncology
[2] Université Paris Descartes,Department of Biostatistics
[3] Institut Curie,Department of Medical Oncology
[4] Centre Léon Bérard,Department of Medical Oncology
[5] Institut Gustave Roussy,Department of Medical Oncology
[6] Institut Curie,Department of Medical Oncology
[7] Hôpital René Huguenin,Hematology laboratory
[8] Institut de Cancérologie de l'Ouest,undefined
[9] Bd Monod,undefined
[10] Institut Curie,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Progression Free Survival; Metastatic Breast Cancer; Circulate Tumor Cell; Serum Marker; Metastatic Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer [J].
Volkmar Müller ;
Sabine Riethdorf ;
Brigitte Rack ;
Wolfgang Janni ;
Peter A Fasching ;
Erich Solomayer ;
Bahriye Aktas ;
Sabine Kasimir-Bauer ;
Julia Zeitz ;
Klaus Pantel ;
Tanja Fehm .
Breast Cancer Research, 13
[32]   Design of cancer trials based on progression-free survival with intermittent assessment [J].
Zeng, Leilei ;
Cook, Richard J. ;
Lee, Ker-Ai .
STATISTICS IN MEDICINE, 2018, 37 (12) :1947-1959
[33]   A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer [J].
Tanase, Takanori ;
Hamada, Chikuma ;
Yoshino, Takayuki ;
Ohtsu, Atsushi .
ANTICANCER RESEARCH, 2017, 37 (10) :5851-5855
[34]   Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival [J].
Rochefort, Pauline ;
Chabaud, Sylvie ;
Pierga, Jean-Yves ;
Tredan, Olivier ;
Brain, Etienne ;
Bidard, Francois-Clement ;
Schiffler, Camille ;
Polena, Helena ;
Khalil-Mgharbel, Abir ;
Vilgrain, Isabelle ;
Bachelot, Thomas .
BRITISH JOURNAL OF CANCER, 2017, 116 (03) :356-361
[35]   Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival [J].
Pauline Rochefort ;
Sylvie Chabaud ;
Jean-Yves Pierga ;
Olivier Tredan ;
Etienne Brain ;
François-Clément Bidard ;
Camille Schiffler ;
Helena Polena ;
Abir Khalil-Mgharbel ;
Isabelle Vilgrain ;
Thomas Bachelot .
British Journal of Cancer, 2017, 116 :356-361
[36]   Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer [J].
Svensson, Helene ;
Hatschek, Thomas ;
Johansson, Hemming ;
Einbeigi, Zakaria ;
Brandberg, Yvonne .
MEDICAL ONCOLOGY, 2012, 29 (02) :432-438
[37]   Clinical Utility of Serum Tumor Markers and Circulating Tumor Cell Assays in the Treatment of Breast Cancer [J].
Vandana G. Abramson ;
Ingrid A. Mayer .
Current Treatment Options in Oncology, 2011, 12 :403-411
[38]   Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer [J].
Helene Svensson ;
Thomas Hatschek ;
Hemming Johansson ;
Zakaria Einbeigi ;
Yvonne Brandberg .
Medical Oncology, 2012, 29 :432-438
[39]   Prediction of Survival and Progression-free Survival Using Machine Learning in Stage III Lung Cancer: A Pilot Study [J].
Yakar, Melek ;
Etiz, Durmus ;
Yilmaz, Senay ;
Celik, Ozer ;
Guntulu, A. K. ;
Metintas, Muzaffer .
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (04) :446-458
[40]   Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer [J].
Wang, Ying ;
Liu, Yanxia ;
Zhang, Lina ;
Tong, Li ;
Gao, Yuan ;
Hu, Fanbin ;
Lin, Peter Ping ;
Li, Baolan ;
Zhang, Tongmei .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (12) :2911-2920
12345